Cargando…

Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives

Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma or endometrioid adenocarcinoma. To improve the survival of patients with ovarian CCC, the deeper understanding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mabuchi, Seiji, Sugiyama, Toru, Kimura, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823362/ https://www.ncbi.nlm.nih.gov/pubmed/27029752 http://dx.doi.org/10.3802/jgo.2016.27.e31

Ejemplares similares

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
por: Takahashi, Ryoko, et al.
Publicado: (2016)

Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?
por: Takano, Masashi, et al.
Publicado: (2012)

Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
por: Matsuzaki, Shinya, et al.
Publicado: (2015)

Clear-Cell Carcinoma of the Ovary with Bilateral Breast Metastases
por: Galili, Yehuda, et al.
Publicado: (2019)

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
por: Zhang, Xiaonan, et al.
Publicado: (2021)

Are platinum agents, paclitaxel and irinotecan effective for clear cell carcinoma of the ovary? DNA damage detected with γH2AX induced by anticancer agents
por: Takatori, Eriko, et al.
Publicado: (2012)

Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2011)

Surgical management of non-invasive uterine clear cell carcinoma
por: Sugiyama, Toru, et al.
Publicado: (2017)

Ruptured clear cell carcinoma of the ovary presenting as acute abdomen
por: Zhou, Zhen Ni, et al.
Publicado: (2016)

Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review)
por: UEKURI, CHIHARU, et al.
Publicado: (2013)

Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary
por: Mori, Hidemi, et al.
Publicado: (2023)

Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature Review
por: Amano, Tsukuru, et al.
Publicado: (2019)

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
por: Takano, M, et al.
Publicado: (2006)

Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma
por: Zhu, Chenchen, et al.
Publicado: (2021)

Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma
por: Yokoi, Eriko, et al.
Publicado: (2017)

Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary
por: Yamada, Takashi, et al.
Publicado: (2016)

Borderline Clear Cell Adenofibroma of the Ovary
por: Kleebkaow, Pilaiwan, et al.
Publicado: (2017)

Clear cell carcinoma of the ovary: multi-slice computed tomography findings
por: Li, Xubin, et al.
Publicado: (2015)

Sensitivity to Anticancer Agents and Resistance Mechanisms in Clear Cell Carcinoma of the Ovary
por: Itamochi, Hiroaki, et al.
Publicado: (2002)

Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
por: Morioka, Sachiko, et al.
Publicado: (2019)

New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
por: Tan, D S P, et al.
Publicado: (2013)

Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
por: Shimura, Kotaro, et al.
Publicado: (2013)

Clear cell carcinoma of ovary with squamous metaplasia: A unique histopathological observation
por: Das, Prasenjit, et al.
Publicado: (2011)

Clear cell carcinoma of the ovary: Clinicopathologic features and outcomes in a Chinese cohort
por: Tang, Haosha, et al.
Publicado: (2018)

SR-B1 and CD10 combined immunoprofile for differential diagnosis of metastatic clear cell renal cell carcinoma and clear cell carcinoma of the ovary
por: Jiang, Teng, et al.
Publicado: (2021)

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma
por: Itamochi, Hiroaki, et al.
Publicado: (2017)

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report
por: Takatori, Eriko, et al.
Publicado: (2014)

Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma
por: Nishida, K., et al.
Publicado: (2016)

PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma
por: Wang, Jianfeng, et al.
Publicado: (2021)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

Endometriosis in clear cell and endometrioid carcinoma ovary: its impact on clinicopathological characteristics and survival outcomes
por: Kundur, Mythili, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols
por: Sortino, Maria A., et al.
Publicado: (2017)

Clear Cell Borderline Tumor of the Ovary: A Case Report
Publicado: (2023)

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
por: Amano, Tsukuru, et al.
Publicado: (2021)

Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications
por: Wolf, Melissa M., et al.
Publicado: (2020)

Mural Nodules of Clear Cell Carcinoma in a Mucinous Borderline Tumor of the Ovary: A Case Report
por: Allende, Daniela S., et al.
Publicado: (2010)

X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary
por: Miyamoto, M, et al.
Publicado: (2014)

Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes
por: Hsu, Yueh-Han, et al.
Publicado: (2020)

Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
por: Miyamoto, Morikazu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qt3pu5gpcak4ojrdabd62dgog5